相关实验视频
Updated: Jul 28, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
12.0K
设计,合成,分子动力学模拟,MM/GBSA研究和对一些4 - 氨基诺林混合物的基因素螺旋蛋白抑制评价
Shriram D Ranade1, Shankar G Alegaon1, U Venkatasubramanian2
1Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India.
Computational biology and chemistry
|May 31, 2023
概括
研究人员开发了新的4-氨基类化合物,作为癌症治疗的Eg5 (素家族运动蛋白) 的潜在抑制剂. 化合物4和6c显示出显著的Eg5抑制,显示出未来药物开发的希望.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 基因素家族运动蛋白Eg5是抗癌药物开发的关键标,因为它在线粒分裂中的作用.
- 开发针对Eg5的新型化疗剂仍然是研究人员面临的重大挑战.
研究的目的:
- 设计,合成和评估4 - 氨基诺林混合化合物作为潜在的Eg5抑制剂.
- 为了确定具有强大的Eg5抑制活性的特定化合物.
主要方法:
- 合成4 - 氨基诺林混合化合物.
- 试验室试验包括马六合绿色和稳定状态ATPase试验.
- 计算方法:分子对接,MM/GBSA,以及分子动态模拟.
主要成果:
- 化合物6c,6d,6g和6h对Eg5抑制表现出敏感性.
- 化合物4和6c在马六合绿色试验中表现出强烈的抑制作用 (IC50值~2μM).
- 化合物4在稳定状态ATPase试验 (IC50值~5.4μM) 中显示出有利的抑制潜力.
结论:
- 合成的4 - 氨基诺林希夫基混合物是新型Eg5抑制剂的有希望的候选者.
- 进一步的体内研究是有必要的,以探索它们的治疗潜力.
- 这些化合物可能会导致用于癌症治疗的新化疗剂.
更多相关视频
相关概念视频
Structure-Activity Relationships and Drug Design
801
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
801
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K

